Furthermore, as an inhibitor of nuclear factor kappa B (NF-κB), celastrol attenuates inflammatory responses, which in turn helps to reduce insulin resistance (Faheem et al. 2025). The gene discussed is NFKB1; the disease is Insulin resistance.